Practical guidance on the use of sacubitril/valsartan for heart failure.
Journal Information
Full Title: Heart Fail Rev
Abbreviation: Heart Fail Rev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Author disclosuresDrs. Sauer and Cole have received speaker honoraria from Novartis. Dr. Sharma has received speaker honoraria from Novartis, Bayer, and Servier. Drs. Jensen, Pal, Yehya, and Vader have no relationships relevant to the contents of this paper to disclose.: Ethical approvalFor this type of study, formal consent is not required.: Research involving human participants and/or animalsThe article does not contain studies with human participants or animals performed by any of the authors.: Informed consentNot applicable."
"Funding Medical writing assistance for this manuscript was provided by Oxford PharmaGenesis, Inc., Newtown, Pennsylvania, USA, and was funded by Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025